Literature DB >> 30773290

Monogenic causes of chronic kidney disease in adults.

Dervla M Connaughton1, Claire Kennedy2, Shirlee Shril3, Nina Mann3, Susan L Murray2, Patrick A Williams4, Eoin Conlon4, Makiko Nakayama3, Amelie T van der Ven3, Hadas Ityel3, Franziska Kause3, Caroline M Kolvenbach3, Rufeng Dai3, Asaf Vivante5, Daniela A Braun3, Ronen Schneider3, Thomas M Kitzler3, Brona Moloney2, Conor P Moran6, John S Smyth6, Alan Kennedy7, Katherine Benson8, Caragh Stapleton8, Mark Denton2, Colm Magee2, Conall M O'Seaghdha2, William D Plant9, Matthew D Griffin10, Atif Awan11, Clodagh Sweeney11, Shrikant M Mane12, Richard P Lifton13, Brenda Griffin7, Sean Leavey14, Liam Casserly15, Declan G de Freitas2, John Holian16, Anthony Dorman17, Brendan Doyle18, Peter J Lavin19, Mark A Little7, Peter J Conlon20, Friedhelm Hildebrandt21.   

Abstract

Approximately 500 monogenic causes of chronic kidney disease (CKD) have been identified, mainly in pediatric populations. The frequency of monogenic causes among adults with CKD has been less extensively studied. To determine the likelihood of detecting monogenic causes of CKD in adults presenting to nephrology services in Ireland, we conducted whole exome sequencing (WES) in a multi-centre cohort of 114 families including 138 affected individuals with CKD. Affected adults were recruited from 78 families with a positive family history, 16 families with extra-renal features, and 20 families with neither a family history nor extra-renal features. We detected a pathogenic mutation in a known CKD gene in 42 of 114 families (37%). A monogenic cause was identified in 36% of affected families with a positive family history of CKD, 69% of those with extra-renal features, and only 15% of those without a family history or extra-renal features. There was no difference in the rate of genetic diagnosis in individuals with childhood versus adult onset CKD. Among the 42 families in whom a monogenic cause was identified, WES confirmed the clinical diagnosis in 17 (40%), corrected the clinical diagnosis in 9 (22%), and established a diagnosis for the first time in 16 families referred with CKD of unknown etiology (38%). In this multi-centre study of adults with CKD, a molecular genetic diagnosis was established in over one-third of families. In the evolving era of precision medicine, WES may be an important tool to identify the cause of CKD in adults.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic kidney disease; genetic kidney disease; whole exome sequencing

Mesh:

Year:  2019        PMID: 30773290      PMCID: PMC6431580          DOI: 10.1016/j.kint.2018.10.031

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

1.  Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study.

Authors:  Sneh Lata; Maddalena Marasa; Yifu Li; David A Fasel; Emily Groopman; Vaidehi Jobanputra; Hila Rasouly; Adele Mitrotti; Rik Westland; Miguel Verbitsky; Jordan Nestor; Lindsey M Slater; Vivette D'Agati; Marcin Zaniew; Anna Materna-Kiryluk; Francesca Lugani; Gianluca Caridi; Luca Rampoldi; Aditya Mattoo; Chad A Newton; Maya K Rao; Jai Radhakrishnan; Wooin Ahn; Pietro A Canetta; Andrew S Bomback; Gerald B Appel; Corinne Antignac; Glen S Markowitz; Christine K Garcia; Krzysztof Kiryluk; Simone Sanna-Cherchi; Ali G Gharavi
Journal:  Ann Intern Med       Date:  2017-12-05       Impact factor: 25.391

2.  Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders.

Authors:  Andrew J Mallett; Hugh J McCarthy; Gladys Ho; Katherine Holman; Elizabeth Farnsworth; Chirag Patel; Jeffery T Fletcher; Amali Mallawaarachchi; Catherine Quinlan; Bruce Bennetts; Stephen I Alexander
Journal:  Kidney Int       Date:  2017-08-23       Impact factor: 10.612

3.  Whole-Exome Sequencing Reveals FAT4 Mutations in a Clinically Unrecognizable Patient with Syndromic CAKUT: A Case Report.

Authors:  Amelie T van der Ven; Shirlee Shril; Hadas Ityel; Asaf Vivante; Jing Chen; Daw-Yang Hwang; Kristen M Laricchia; Monkol Lek; Velibor Tasic; Friedhelm Hildebrandt
Journal:  Mol Syndromol       Date:  2017-07-01

4.  The Irish Kidney Gene Project--Prevalence of Family History in Patients with Kidney Disease in Ireland.

Authors:  Dervla M Connaughton; Sarah Bukhari; Peter Conlon; Eoin Cassidy; Michael O'Toole; Mardina Mohamad; John Flanagan; Triona Butler; Anne O'Leary; Limy Wong; John O'Regan; Sarah Moran; Patrick O'Kelly; Valerie Logan; Brenda Griffin; Matthew Griffin; Peter Lavin; Mark A Little; Peter Conlon
Journal:  Nephron       Date:  2015-07-18       Impact factor: 2.847

5.  Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD).

Authors:  Carsten Bergmann; Jan Senderek; Ellen Windelen; Fabian Küpper; Iris Middeldorf; Frank Schneider; Christian Dornia; Sabine Rudnik-Schöneborn; Martin Konrad; Claus P Schmitt; Tomas Seeman; Thomas J Neuhaus; Udo Vester; Jutta Kirfel; Reinhard Büttner; Klaus Zerres
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

6.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

7.  Familial clustering of ESRD in the Norwegian population.

Authors:  Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

8.  Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.

Authors:  Veronique Frémeaux-Bacchi; Elizabeth C Miller; M Kathryn Liszewski; Lisa Strain; Jacques Blouin; Alison L Brown; Nadeem Moghal; Bernard S Kaplan; Robert A Weiss; Karl Lhotta; Gaurav Kapur; Tej Mattoo; Hubert Nivet; William Wong; Sophie Gie; Bruno Hurault de Ligny; Michel Fischbach; Ritu Gupta; Richard Hauhart; Vincent Meunier; Chantal Loirat; Marie-Agnès Dragon-Durey; Wolf H Fridman; Bert J C Janssen; Timothy H J Goodship; John P Atkinson
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

Review 9.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Authors:  Ron T Gansevoort; Ricardo Correa-Rotter; Brenda R Hemmelgarn; Tazeen H Jafar; Hiddo J Lambers Heerspink; Johannes F Mann; Kunihiro Matsushita; Chi Pang Wen
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

10.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

View more
  61 in total

1.  Personalized medicine in chronic kidney disease by detection of monogenic mutations.

Authors:  Dervla M Connaughton; Friedhelm Hildebrandt
Journal:  Nephrol Dial Transplant       Date:  2020-03-01       Impact factor: 5.992

2.  Clinical Genetic Screening in Adult Patients with Kidney Disease.

Authors:  Enrico Cocchi; Jordan Gabriela Nestor; Ali G Gharavi
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-09       Impact factor: 8.237

3.  Expanding opportunities and emerging challenges: broadening the scope of genetic testing in nephrology.

Authors:  Emily E Groopman; Ali G Gharavi
Journal:  Kidney Int       Date:  2019-04       Impact factor: 10.612

4.  De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis.

Authors:  Patricia L Weng; Amar J Majmundar; Kamal Khan; Tze Y Lim; Shirlee Shril; Gina Jin; John Musgrove; Minxian Wang; Dina F Ahram; Vimla S Aggarwal; Louise E Bier; Erin L Heinzen; Ana C Onuchic-Whitford; Nina Mann; Florian Buerger; Ronen Schneider; Konstantin Deutsch; Thomas M Kitzler; Verena Klämbt; Amy Kolb; Youying Mao; Christelle Moufawad El Achkar; Adele Mitrotti; Jeremiah Martino; Bodo B Beck; Janine Altmüller; Marcus R Benz; Shoji Yano; Mohamad A Mikati; Talha Gunduz; Heidi Cope; Vandana Shashi; Howard Trachtman; Monica Bodria; Gianluca Caridi; Isabella Pisani; Enrico Fiaccadori; Asmaa S AbuMaziad; Julian A Martinez-Agosto; Ora Yadin; Jonathan Zuckerman; Arang Kim; Ulrike John-Kroegel; Amanda V Tyndall; Jillian S Parboosingh; A Micheil Innes; Agnieszka Bierzynska; Ania B Koziell; Mordi Muorah; Moin A Saleem; Julia Hoefele; Korbinian M Riedhammer; Ali G Gharavi; Vaidehi Jobanputra; Emma Pierce-Hoffman; Eleanor G Seaby; Anne O'Donnell-Luria; Heidi L Rehm; Shrikant Mane; Vivette D D'Agati; Martin R Pollak; Gian Marco Ghiggeri; Richard P Lifton; David B Goldstein; Erica E Davis; Friedhelm Hildebrandt; Simone Sanna-Cherchi
Journal:  Am J Hum Genet       Date:  2021-01-27       Impact factor: 11.025

Review 5.  Genetic testing for kidney disease of unknown etiology.

Authors:  Thomas Hays; Emily E Groopman; Ali G Gharavi
Journal:  Kidney Int       Date:  2020-04-24       Impact factor: 10.612

Review 6.  Rare genetic causes of complex kidney and urological diseases.

Authors:  Emily E Groopman; Gundula Povysil; David B Goldstein; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2020-08-17       Impact factor: 28.314

7.  Loss of Arhgef11 in the Dahl Salt-Sensitive Rat Protects Against Hypertension-Induced Renal Injury.

Authors:  Ashley C Johnson; Wenjie Wu; Esinam M Attipoe; Jennifer M Sasser; Erin B Taylor; Kurt C Showmaker; Patrick B Kyle; Merry L Lindsey; Michael R Garrett
Journal:  Hypertension       Date:  2020-03-09       Impact factor: 10.190

Review 8.  Podocytopathies.

Authors:  Jeffrey B Kopp; Hans-Joachim Anders; Katalin Susztak; Manuel A Podestà; Giuseppe Remuzzi; Friedhelm Hildebrandt; Paola Romagnani
Journal:  Nat Rev Dis Primers       Date:  2020-08-13       Impact factor: 52.329

9.  Utility of Genomic Testing after Renal Biopsy.

Authors:  Susan L Murray; Anthony Dorman; Katherine A Benson; Dervla M Connaughton; Caragh P Stapleton; Neil K Fennelly; Claire Kennedy; Ciara A McDonnell; Kendrah Kidd; Sarah M Cormican; Louise A Ryan; Peter Lavin; Mark A Little; Anthony J Bleyer; Brendan Doyle; Gianpiero L Cavalleri; Friedhelm Hildebrandt; Peter J Conlon
Journal:  Am J Nephrol       Date:  2019-12-10       Impact factor: 3.754

10.  Preimplantation Genetic Testing for Monogenic Kidney Disease.

Authors:  Rozemarijn Snoek; Marijn F Stokman; Klaske D Lichtenbelt; Theodora C van Tilborg; Cindy E Simcox; Aimée D C Paulussen; Jos C M F Dreesen; Franka van Reekum; A Titia Lely; Nine V A M Knoers; Christine E M de Die-Smulders; Albertien M van Eerde
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-27       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.